Possible hypoglycemic action of SX-fraction targeting insulin signal transduction pathway

BACKGROUND: SX-fraction (SXF) is a bioactive glycoprotein with hypoglycemic activity that has been demonstrated in our pilot clinical study. However, how it would actually work in diabetic patients remains unclear. To explore such a mechanism, the effects of SXF on the insulin signal transduction pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Konno, Sensuke, Alexander, Bobby, Zade, John, Choudhury, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615842/
https://www.ncbi.nlm.nih.gov/pubmed/23569395
http://dx.doi.org/10.2147/IJGM.S41891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615842/
https://www.ncbi.nlm.nih.gov/pubmed/23569395
http://dx.doi.org/10.2147/IJGM.S41891

Ejemplares similares